Patent details

EP1799685 Title: POLYMORPHIC FORMS OF THE PHOSPHATE SALT OF 8-FLUORO-2-{4-[(METHYLAMINO)METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-CD]INDOL-6-ONE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP1799685
WO Application Number:
IB2005002941
Type:
European Patent Granted for NL
Status:
Deemed not to be granted
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP05799991.4
WO Publication Number:
WO2006033007
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United Kingdom (GB)
Publications:

Dates

Filing date:
12/09/2005
Grant date:
28/03/2012
EP Publication Date:
28/03/2012
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
28/03/2012
EP B1 Publication Date:
28/03/2012
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
11/09/2025
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
28/03/2012
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
28/03/2012
 
 

 

Name:
Pfizer Inc.
Address:
235 East 42nd Street, NEW YORK, NY 10017, United States of America (US)

From:
28/03/2012
 
 

 

Name:
Cancer Research Technology Limited
Address:
Sardinia House, Sardinia Street, LONDON WC2A 3NL, United Kingdom (GB)

Inventor

1

Name:
LIU, Jia, Agouron Pharmaceuticals, Inc.
Address:
SAN DIEGO, CA 92121, United States of America (US)

2

Name:
NAYYAR, Naresh, Agouron Pharmaceuticals, Inc.
Address:
SAN DIEGO, CA 92121, United States of America (US)

3

Name:
GUO, Ming Agouron Pharmaceuticals, Inc. A Pfizer Company
Address:
SAN DIEGO, CA 92121, United States of America (US)

4

Name:
WU, Zhen-Ping, Agouron Pharmaceuticals, Inc.
Address:
SAN DIEGO, CA 92121, United States of America (US)

5

Name:
BORER Bennett C., Agouron Pharmaceuticals, Inc.
Address:
SAN DIEGO, CA 92121, United States of America (US)

6

Name:
SRIRANGAM, A.N., Agouron Pharmaceuticals, Inc.
Address:
SAN DIEGO, CA 92121, United States of America (US)

7

Name:
MITCHELL, Mark B., Agouron Pharmaceuticals, Inc.
Address:
SAN DIEGO, CA 92121, United States of America (US)

8

Name:
LI, Yi, Agouron Pharmaceuticals, Inc.
Address:
SAN DIEGO, CA 92121, United States of America (US)

9

Name:
CHU, Jan-Jon, Agouron Pharmaceuticals, Inc.
Address:
SAN DIEGO, CA92121, United States of America (US)

Priority

1

Priority Patent Number:
679296 P
Priority Date:
09/05/2005
Priority Country:
United States of America (US)

2

Priority Patent Number:
612459 P
Priority Date:
22/09/2004
Priority Country:
United States of America (US)

Classification

Main IPC Class:
C07D 487/06;
IPC or IDT classification:
A61K 31/55; A61P 25/00; A61P 35/00;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
2012/29
Publication date:
18/07/2012
Description:
Lapse or annulment

2

Bulletin Heading:
EP2
Journal edition number:
2012/14
Publication date:
04/04/2012
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201213
Publication date:
28/03/2012
Description:
Grant (B1)
Filing date Document type Document Description Number of pages File Type